Our results showed that LL‐Z1640‐2 and patulin are promising compounds that decrease ZIC5 expression levels and induce apoptosis in various cancer cells, including melanoma, BRAF‐inhibitor resistant melanoma, pancreatic cancer and cholangiocarcinoma cells. Here, ZIC5 is linked to cancer.